Search Within

Department of Medicine

Formats
  1. Journal Article (19620)
  2. Meeting Abstract (16084)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22367)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10658)
  5. Survivorship Research (9352)
  6. Division of Subspecialty Medicine (7560)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1158)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39711)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Triplet therapy in metastatic hormone-sensitive prostate cancer-calling out the "double Standard"
    Editorial

    McHugh, D. J.; Scher, H. I.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Treatment with liposomal irinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: The phase 2b NIFTY randomized clinical trial
    Journal Article

    Hyung, J.; Kim, I.; Kim, K. P.; Ryoo, B. Y.; Jeong, J. H.; Kang, M. J.; Cheon, J.; Kang, B. W.; Ryu, H.; Lee, J. S.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Early detection and prognostic assessment of cutaneous melanoma: Consensus on optimal practice and the role of gene expression profile testing
    Review

    Kashani-Sabet, M.; Leachman, S. A.; Stein, J. A.; Arbiser, J. L.; Berry, E. G.; Celebi, J. T.; Curiel-Lewandrowski, C.; Ferris, L. K.; Grant-Kels, J. M.; Grossman, D.; more...
    JAMA Dermatology (2023)

    Fulltext@MSK | Save
  • Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy: A randomized clinical trial
    Journal Article

    D'Angelica, M. I.; Ellis, R. J.; Liu, J. B.; Brajcich, B. C.; Gönen, M.; Thompson, V. M.; Cohen, M. E.; Seo, S. K.; Zabor, E. C.; Babicky, M. L.; more...
    JAMA - Journal of the American Medical Association (2023)

    Fulltext@MSK | Save
  • Predictive biomarkers for immune-checkpoint inhibitor treatment response in patients with hepatocellular carcinoma
    Review

    Ji, J. H.; Ha, S. Y.; Lee, D.; Sankar, K.; Koltsova, E. K.; Abou-Alfa, G. K.; Yang, J. D.
    International Journal of Molecular Sciences (2023)

    Fulltext@MSK | Save
  • The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study
    Journal Article

    Sia, T. Y.; Tew, W. P.; Purdy, C.; Chi, D. S.; Menzin, A. W.; Lovecchio, J. L.; Bookman, M. A.; Cohn, D. E.; Teoh, D. G.; Friedlander, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations
    Review

    Rimel, B. J.; Crane, E. K.; Hou, J.; Nakayama, J.; MacDonald, J.; Lutz, K.; Makker, V.; O'Cearbhaill, R. E.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcomas
    Journal Article

    Sia, T. Y.; Gordhandas, S. B.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M. L.; Rubinstein, M.; Makker, V.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Plain language summary of the development of tepotinib: A treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping
    Review

    Hallick, J.; Baird, A. M.; Falchook, G.; Le, X.; Hong, D.; Viteri, S.; Raskin, J.; Reinmuth, N.; Vlassak, S.; Militaru, M.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: Final analysis of KEYNOTE-164
    Journal Article

    Le, D. T.; Diaz, L. A. Jr; Kim, T. W.; Van Cutsem, E.; Geva, R.; Jäger, D.; Hara, H.; Burge, M.; O'Neil, B. H.; Kavan, P.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save